ReviewDrugs2021

Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences.

C Louwrens Braal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.